These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 11496883)
1. Neomycin should not be used to treat hepatic encephalopathy. Curioso WH; Monkemuller KE BMJ; 2001 Jul; 323(7306):233. PubMed ID: 11496883 [No Abstract] [Full Text] [Related]
2. Alcoholic hepatitis. Mohammed F N Engl J Med; 2009 Oct; 361(15):1512; author reply 1512-3. PubMed ID: 19812414 [No Abstract] [Full Text] [Related]
4. [Nonabsorbable disaccharides for the treatment of hepatic encephalopathy--a systemic review of randomized clinical trials--a secondary publication]. Als-Nielsen BE; Gluud LL; Gluud CN Ugeskr Laeger; 2005 Jan; 167(2):179-82. PubMed ID: 15697132 [No Abstract] [Full Text] [Related]
5. [Use of neomycin in the treatment of acute hepatoportal encephalopathy]. Gubskiĭ LV; Ershov IuA Klin Med (Mosk); 1976 Apr; 54(4):110-5. PubMed ID: 1016352 [No Abstract] [Full Text] [Related]
6. Double-blind randomized clinical trial comparing neomycin and placebo in the treatment of exogenous hepatic encephalopathy. Strauss E; Tramote R; Silva EP; Caly WR; Honain NZ; Maffei RA; de Sá MF Hepatogastroenterology; 1992 Dec; 39(6):542-5. PubMed ID: 1483668 [TBL] [Abstract][Full Text] [Related]
7. Antibiotic therapy in the management of hepatic coma. FAST BB; WOLFE SJ; STORMONT JM; DAVIDSON CS AMA Arch Intern Med; 1958 Feb; 101(2):467-75. PubMed ID: 13497350 [No Abstract] [Full Text] [Related]
8. [Update on the management of hepatic encephalopathy]. García Martínez R; Córdoba Cardona J Rev Esp Enferm Dig; 2008 Oct; 100(10):637-44. PubMed ID: 19119790 [No Abstract] [Full Text] [Related]
9. [Lactulose-neomycin combination versus placebo in the treatment of acute hepatic encephalopathy. Results of a randomized controlled trial]. Blanc P; Daurès JP; Liautard J; Buttigieg R; Desprez D; Pageaux G; Allaz JL; Parelon G; Larrey D; Michel H Gastroenterol Clin Biol; 1994; 18(12):1063-8. PubMed ID: 7750678 [TBL] [Abstract][Full Text] [Related]
10. Portal systemic encephalopathy--should lactulose and neomycin be used together. Martin AJ Br J Clin Pract; 1981 Sep; 35(9):323-4. PubMed ID: 7326185 [No Abstract] [Full Text] [Related]
11. Rifaximine versus neomycin in the treatment of portosystemic encephalopathy. Di Piazza S; Gabriella Filippazzo M; Valenza LM; Morello S; Pastore L; Conti A; Cottone S; Pagliaro L Ital J Gastroenterol; 1991; 23(7):403-7. PubMed ID: 1742538 [TBL] [Abstract][Full Text] [Related]
12. [Comparative study of lactulose and neomycin in the treatment of porto-systemic encephalopathy]. Sala Felis T; Berenguer J; Barrios JM; Gómez J Rev Esp Enferm Apar Dig; 1974 Feb; 42(3):335-42. PubMed ID: 4829021 [No Abstract] [Full Text] [Related]
13. [Letter: neomycin in hepatic coma]. Müting D Dtsch Med Wochenschr; 1973 Sep; 98(38):1783. PubMed ID: 4200493 [No Abstract] [Full Text] [Related]
14. [Lactitol and neomycin: monotherapy or combined therapy in the prevention and treatment of hepatic encephalopathy?]. Scevola D; Zambelli A; Concia E; Perversi L; Candiani C Clin Ter; 1989 Apr; 129(2):105-11. PubMed ID: 2525995 [TBL] [Abstract][Full Text] [Related]
15. Erythromycin versus neomycin in the treatment of hepatic encephalopathy in cirrhosis: a randomized double-blind study. Romeiro FG; da Silva Yamashiro F; Américo MF; Corá LA; Silva GF; Miranda JR; Caramori CA BMC Gastroenterol; 2013 Jan; 13():13. PubMed ID: 23324408 [TBL] [Abstract][Full Text] [Related]